NYSE - Delayed Quote USD

Doximity, Inc. (DOCS)

Time to buy DOCS?

59.35

+0.99

+(1.70%)

At close: May 8 at 4:00:02 PM EDT

59.47

+0.12

+(0.20%)

After hours: May 8 at 7:58:37 PM EDT

Time to buy DOCS?

Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates

Progyny (PGNY) delivered earnings and revenue surprises of 6.67% and 6.60%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 hours ago

PGNY

DOCS
+1.70%
3 Reasons We Love Doximity (DOCS)

Doximity has been treading water for the past six months, holding steady at $58. However, the stock is beating the S&P 500’s 6.2% decline during that period.

StockStory 21 hours ago

DOCS
+1.70%
Doximity (DOCS) Gains As Market Dips: What You Should Know

Doximity (DOCS) concluded the recent trading session at $59.39, signifying a +0.1% move from its prior day's close.

Zacks 3 days ago

DOCS
+1.70%
1 Cash-Producing Stock with Impressive Fundamentals and 2 to Think Twice About

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

StockStory 3 days ago

AMN

MED

DOCS
+1.70%
3 Quality Compounders to Own for Decades

A quality compounder is a business that not only sports durable competitive advantages but also builds on its success by consistently reinvesting its profits at high returns.

StockStory 7 days ago

CMG

DOCS
+1.70%

TXRH
SOLV vs. DOCS: Which Stock Is the Better Value Option?

SOLV vs. DOCS: Which Stock Is the Better Value Option?

Zacks 9 days ago

DOCS
+1.70%
Is Coya Therapeutics, Inc. (COYA) Outperforming Other Medical Stocks This Year?

Here is how Coya Therapeutics, Inc. (COYA) and Doximity (DOCS) have performed compared to their sector so far this year.

Zacks 9 days ago

COYA

DOCS
+1.70%
Doximity (DOCS) Ascends But Remains Behind Market: Some Facts to Note

In the closing of the recent trading day, Doximity (DOCS) stood at $56.65, denoting a +0.64% change from the preceding trading day.

Zacks 13 days ago

DOCS
+1.70%
Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

SAN FRANCISCO, April 24, 2025--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2025 after market close on May 15, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.

Business Wire 14 days ago

DOCS
+1.70%
Why Doximity, Inc. (DOCS) Is Among the Best Telehealth Stocks to Buy Now

We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to take a look at where Doximity, Inc. (NYSE:DOCS) stands against other best telehealth stocks to buy right now. Overview of the American Telehealth Industry According to Grand View Research, the telehealth market size in the […]

Insider Monkey 17 days ago

DOCS
+1.70%
Insider-Favored Growth Stocks To Watch In April 2025

As the U.S. market grapples with new restrictions on chip exports to China, causing notable declines in major indices like the S&P 500 and Nasdaq Composite, investors are increasingly looking for resilient opportunities amid this volatility. In such an environment, growth companies with high insider ownership can offer a unique appeal, as their significant internal backing often signals confidence in long-term potential despite short-term market fluctuations.

Simply Wall St. 22 days ago

UPST

WK

DOCS
+1.70%
Vertical Software Stocks Q4 In Review: Doximity (NYSE:DOCS) Vs Peers

Looking back on vertical software stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Doximity (NYSE:DOCS) and its peers.

StockStory 24 days ago

DOCS
+1.70%

AGYS

UPST
Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy?

Both TEM and DOCS are technology-intensive healthcare companies leveraging artificial intelligence to enhance their platforms. Which one is a better investment? Let's see.

Zacks 27 days ago

DOCS
+1.70%

TEM
Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?

Here is how Enhabit (EHAB) and Doximity (DOCS) have performed compared to their sector so far this year.

Zacks 28 days ago

EHAB

DOCS
+1.70%
Trump Tariffs Trigger Bear Market. Investor Focus Shifts Here.

A bear market takes hold as Trump tariffs hammer stocks. With IBD Leaderboard trimmed to just seven names, safety and preparation are in focus.

Investor's Business Daily last month

AS

AEM

OLLI
Calculating The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Key Insights Doximity's estimated fair value is US$55.49 based on 2 Stage Free Cash Flow to Equity With US$51.24 share...

Simply Wall St. last month

DOCS
+1.70%
5 Momentum Stocks to Buy for April Despite a Disappointing March

Five stocks have strong momentum for April. These are: APP, MRVL, DOCS, RDDT, VEEV.

Zacks last month

COMP

^GSPC

MRVL
Zacks Industry Outlook Highlights Cencora, Doximity and Pediatrix Medical

Cencora, Doximity and Pediatrix Medical are part of the Zacks Industry Outlook article.

Zacks last month

DOCS
+1.70%

^GSPC
Doximity (DOCS) Falls More Steeply Than Broader Market: What Investors Need to Know

Doximity (DOCS) closed at $60.55 in the latest trading session, marking a -1.51% move from the prior day.

Zacks last month

DOCS
+1.70%
3 Medical Services Industry Stocks to Buy as AI Fuels Growth

The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most. Healthcare staffing shortages are leading to an increase in labor wages.

Zacks last month

^GSPC

DOCS
+1.70%

Performance Overview

Return	DOCS	S&P 500 (^GSPC)
YTD	+11.16%	-3.70%
1-Year	+148.53%	+9.18%
3-Year	+71.28%	+37.36%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Doximity, Inc. (DOCS)

Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates

3 Reasons We Love Doximity (DOCS)

Doximity (DOCS) Gains As Market Dips: What You Should Know

1 Cash-Producing Stock with Impressive Fundamentals and 2 to Think Twice About

3 Quality Compounders to Own for Decades

SOLV vs. DOCS: Which Stock Is the Better Value Option?

Is Coya Therapeutics, Inc. (COYA) Outperforming Other Medical Stocks This Year?

Doximity (DOCS) Ascends But Remains Behind Market: Some Facts to Note

Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

Why Doximity, Inc. (DOCS) Is Among the Best Telehealth Stocks to Buy Now

Insider-Favored Growth Stocks To Watch In April 2025

Vertical Software Stocks Q4 In Review: Doximity (NYSE:DOCS) Vs Peers

Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy?

Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?

Trump Tariffs Trigger Bear Market. Investor Focus Shifts Here.

Calculating The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

5 Momentum Stocks to Buy for April Despite a Disappointing March

Zacks Industry Outlook Highlights Cencora, Doximity and Pediatrix Medical

Doximity (DOCS) Falls More Steeply Than Broader Market: What Investors Need to Know

3 Medical Services Industry Stocks to Buy as AI Fuels Growth

Performance Overview